Here, we demonstrated that TNFAIP3 mRNA was expressed at low levels in psoriatic patients and the IMQ-induced psoriasis-like dermatitis model and that TNF-α antagonists increased TNFAIP3 expression and attenuated the severity of psoriasis in the mouse model. The gene discussed is TNFAIP3; the disease is skin disorder.